# Yinzhu Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yinzhu-pharma

- Industry: Pharmaceuticals
- Headquarters: Guangzhou, China
- Website: www.yinzhupharma.com
- Latest round: Angel (Jun 15, 2018)
- Investors on record: 2

## About

Established in 2016 and based in Guangzhou, China, Yinzhu Pharma operates as a pharmaceutical company dedicated to providing new antitumor drugs. It has applied for and authorized thirty-five domestic and foreign invention patents. In September 2020, Yinzhu Pharma raised CNY 45 million in series A funding.

The company mainly provides antineoplastic drug carboxylaminotriazole soft capsule, which is a new type of non-cytotoxic chemical drug that acts on the TNF-a target. It mainly used to treat advanced non-small cell lung cancer. Yinzhu Pharma is also researching new drugs for solid tumors, autoimmune diseases, and rare diseases.

## Funding rounds

- Angel, Jun 15, 2018 — Fortune Link, Guangsheng Venture

## Investors

- Fortune Link (https://capitalatlas.ai/funds/fortune-link) — Angel
- Guangsheng Venture — Angel